196 MONDAY • MAY 16 P1487 P1488 P1489 P1490 The Imbanlance of Oxidant/Antioxidant Caused by Nitrate in Particulate of Cigarette Smoke May Influence the Progress of Chronic Obstructive Pulmonary Disease/L. Wang, Y. Hu, H. Li, Hangzhou, China, p.A4109 Proteasome-Dependent MHC I Antigen Presentation Is Altered by Cigarette Smoke/I.E. Keller, A. Dann, C. Lukas, D. Brech, O. Vosyka, E. Noessner, O. Eickelberg, S. Meiners, Munchen, Germany, p.A4110 Quercetogetin Protects Cigarette Smoke Extract (CSE)-Induced Mitophagic Cell Death in Pulmonary Epithelial Cells/J.-W. Park, S. Eun Sook, Incheon, Korea, Republic of, p.A4111 Cigarette Smoke-Induced Accumulation of Oxidized Phosphatidylcholine in COPD Primary Human Lung Fibroblasts: Inhibition by Simvastatin/M.H. Ryu, A.D. Desautels, A. Jha, T.H. Mahood, R. Chaudhary, H. Unruh, C. Carlsten, A. Ravandi, A.J. Halayko, Vancouver, Canada, p.A4112 P1491 Cigarette Smoke Decreases NALP3 Protein Levels/S. Han, J. Jerome, R. Mallampalli, Pittsburgh, PA, p.A4113 P1492 P1493 P1494 P1495 P1496 B61 Mechanisms of Uptake/Egress and Intracellular Fate of Nanoparticles in Primary Rat Alveolar Epithelial Cell Monolayers (RAECM)/E.D. Crandall, A. Sipos, J. Peti-Peterdi, R.H. Chow, Z. Borok, K.-J. Kim, Los Angeles, CA, p.A4114 Toxicants, Salicylic Acid and Toluene Diisocyanate, Enhance Carbachol-Induced Bronchoconstriction in Human Precision-Cut Lung Slices (hPCLS)/J.A. Jude, C. Koziol-White, G. Cao, D. Botelho, W. Jester, R.A. Panettieri, Jr., Philadelphia, PA, p.A4115 Determination of Asbestos Body-Associated Proteins by Laser Scanning Micro-Dissection and Mass Spectrometry/T.N. Perkins, E. Toftgaard Poulsen, J.J. Enghild, A. Ghio, V. Roggli, T.D. Oury, Pittsburgh, PA, p.A4116 Synthesis of a Cross-Linked Hyaluronan Matrix by the Airway Epithelium in Experimental Bronchiolitis Obliterans/D.M. Brass, F.L. Kelly, W.M. Gwinn, C. Brinkley, A. Nagler, D.L. Morgan, M.W. Foster, S.M. Palmer, Durham, NC, p.A4117 Preclinical Development of an Antibody Against EMAP II to Treat Cigarette-Smoke (CS)-Induced Emphysema/K. Koike, E. Beatman, M. Justice, B. Johnstone, M. Clauss, K. Schweitzer, I. Petrache, Denver, CO, p.A7843 THEMATIC POSTER SESSION FIBROBLASTS AND MATRIX IN COPD 9:00 a.m. - 4:15 p.m. MOSCONE CENTER Viewing: Posters will be on display for entire session. Area H, Hall D (North Building, Lower Level) Discussion: 11:00-11:45: authors will be present for individual discussion 11:45-12:45: authors will be present for discussion with assigned facilitators P1019 Combination of Glycopyrronium and Indacaterol Suppressed Carbachol-Induced Fibrotic Responses in Lung Fibroblasts/Y. Namba, S. Togo, M. Traf, K. Kadoya, K.Y. Nagahama, H. Taka, N. Kaga, A. Orimo, X. Liu, K. Takahashi, Tokyo, Japan, p.A4118 P1020 P1021 Role of Growth Differentiation Factor 11 in the Pathogenesis of Chronic Obstructive Pulmonary Disease/K. Onodera, H. Sugiura, M. Yamada, A. Koarai, S. Togo, T. Numakura, R. Tanaka, K. Sato, Y. Hashimoto, K. Abe, Y. Kyogoku, M. Ichinose, Sendai, Japan, p.A4119 The Association Between Emphysema and Genetic Variations of LTBP4, a Protein Related to the Formation of Elastic Fiber Assembly/T. Ishii, S. Chubachi, M. Sasaki, T. Arai, T. Betsuyaku, A. Gemma, K. Kida, Tokyo, Japan, p.A4120 P1022 Fibroblast Growth Factor 23-Mediated FGF Receptor 4 Signaling in Bronchial Epithelial Cells Contributes to Inflammation in COPD Patients/S. Krick, N. Baumlin, S. Dennis, M. Campos, C. Faul, M. Salathe, Miami, FL, p.A4121 P1023 P1024 P1025 P1026 P1027 P1028 P1029 P1030 P1031 P1032 Extracellular Matrix Components Affect Myoblast Proliferation and Differentiation/X. Liu, Z. Song, J. Ren, A. Nelson, F. Makino, H. Basma, S. Swanson, I. Pipinos, S.I. Rennard, Omaha, NE, p.A4122 Extracellular Vesicles (EVs) from Normal Human Lung Fibroblasts Cells (NHLF) and COPD/Pulmonary Emphysema Cells Stimulated by IL-b/TNF-a Mediate Divergent Effects/ F. Makino, J. Ikari, M. Makino, A. Nelson, H. Basma, X. Liu, S.I. Rennard, Omaha, NE, p.A4123 Prenyltransferase Expression and Function in Lung Fibroblasts from Moderate COPD Patients/T.H. Mahood, M.H. Ryu, A. Desautels, O.O. Ojo, G.L. Stelmack, H. Unruh, A.J. Halayko, Winnipeg, Canada, p.A4124 Role of Transforming Growth Factor -b1 and Smad Signaling Pathways in EMT Associated COPD Pathegenesis in Smokers/M.Q. Mahmood, D. Reid, H.K. Muller, D.A. Knight, S.S. Sohal, E.H. Walters, Hobart, Australia, p.A4125 Differential Expression of mRNAs in COPD Lung Fibroblasts Varies with Cell Passage and Inflammatory Stimulation In Vitro/J. Ikari, A. Nelson, L. Smith, T.D. LeVan, S. Iwasawa, Y. Gunji, F. Makino, K. Ikari, M. Farid, X. Wang, H. Basma, X. Liu, D.L. DeMeo, C. Feghali-Bostwick, K. Tatsumi, S.I. Rennard, Omaha, NE, p.A4126 Regulation of Non-Canonical WNT-5A by Primary Human Lung Fibroblasts/F. Ciolek, M. Konigshoff, H.A. Baarsma, Munich, Germany, p.A4127 Priming Adipose Stromal Cells for Enhanced Paracrine Anti-Elastase Activity/K. Ni, M.U. Mukhtar, C. Meador, D. Cao, M. Justice, K. Schweitzer, K.L. March, I. Petrache, Denver, CO, p.A4128 Elastin Degradation of Lung Matrix in Advanced COPD Compared to Normal Lung/Y.Y. Lin, J. He, S. Ma, J. Cantor, T. Usuki, G.M. Turino, New York, NY, p.A4129 PPARg and TGF-b1 Signaling Are Involved in Airway Repair in Cigarette Smoke-Associated Chronic Bronchitis/J. Sailland, N. Baumlin, S. Dennis, S. Krick, M. Salathe, A. Schmid, Miami, FL, p.A4130 Epigenetic Changes in CSE-Exposed Human Lung Fibroblasts/ H. Basma, G. Blankenau, A. Nelson, F. Makino, X. Liu, L. Smith, S.I. Rennard, Omaha, NE, p.A4131 ATS 2016 • San Francisco
MONDAY • MAY 16 197 P1033 P1034 P1035 P1036 P1037 B62 Connective Tissue Growth Factor that Promotes Pulmonary Epithelial Cell Senescence Is a Severity-Dependent Biomarker for COPD/J.-H. Jang, H. Chand, S. Bruse, M. Doyle-Eisele, C. Royer, J. McDonald, Y. Lin, Y. Tesfaigzi, T. Nyunoya, Albuquerque, NM, p.A4132 Little Evidence for Epithelial-Mesenchymal Transition in a Murine Model of Airway Fibrosis Induced by Repeated Naphthalene Exposure/T. Tsuji, M. Itoh, R. Kikuchi, T. Uruma, H. Watanabe, K. Yamaguchi, H. Nakamura, K. Aoshiba, Tokyo, Japan, p.A4133 Low Vitamin K Status Is Associated with COPD and Accelerated Degradation of Mature Elastin/B. De Brouwer, M. Spanbroek, N. Drummen, J. Van Den Ouweland, P. Zanen, C. Vermeer, R. Janssen, Nijmegen, Netherlands, p.A4134 Relationship Between Pulmonary Matrix Metalloproteinases and Emphysema Sub-Types/K. Ostridge, S. Harden, S. Bourne, N. Coombes, R.S.J. Estepar, G. Washko, P. Elkington, K.J. Staples, T.M.A. Wilkinson, Southampton Hampshire, United Kingdom, p.A4135 Matrix Metalloproteinase 10 (MMP10) Is Highly Up-Regulated in M2 Macrophages and Lymphoid Aggregates in Idiopathic Pulmonary Fibrosis/C. Chima-Melton, H.D. Jones, W. Parks, Los Angeles, CA, p.A7844 THEMATIC POSTER SESSION THE BIOLOGY OF SCARRING. WHERE ARE WE NOW 9:00 a.m. - 4:15 p.m. MOSCONE CENTER Viewing: Posters will be on display for entire session. Area M, Hall D (North Building, Lower Level) Discussion: 11:00-11:45: authors will be present for individual discussion 11:45-12:45: authors will be present for discussion with assigned facilitators P1498 P1499 P1500 P1501 Hypoxia Worsens Pulmonary Fibrosis Through Expression of C/EBP Homologous Protein (CHOP)/A. Burman, W.E. Lawson, T.S. Blackwell, H. Tanjore, Nashville, TN, p.A4136 Expression of the Relaxin Receptor RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis: Implications for Relaxin-Based Therapies in Fibrotic Lung Disease/J. Tan, J. Tedrow, Y. Chu, K. Veraldi, Y. Zhang, D. Kass, Pittsburgh, PA, p.A4137 Low Input Ion Torrent RNA-Sequencing of Formalin-Fixed, Paraffin-Embedded (FFPE) Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis/M. Vukmirovic, X. Yan, B. Hu, R. Homer, G. Deluliis, K. Gibson, K.O. Lindell, S.A. Yousem, J.H. Maya, N. Kaminski, New Haven, CT, p.A4138 Integrin-a6 Regulates Cellular Senescence and Pro-fibrotic Gene Expression in IPF Fibroblasts/A.R. Kurundkar, J.S. Deshane, Y. Zhou, D. Kurundkar, L. Hecker, S. Rangarajan, V.J. Thannickal, Birmingham, AL, p.A4139 P1502 P1503 P1504 P1505 P1506 P1507 P1508 P1509 P1510 P1511 P1512 P1513 An Antagonistically Pleiotropic Role of miR-34a in the Pathogenesis of Lung Fibrosis in Young and Aged Mice/H. Cui, S. Banerjee, J. Ge, N. Xie, R.-M. Liu, V.B. Antony, V.J. Thannickal, G. Liu, Birmingham, AL, p.A4140 Elderly-Onset Hereditary Pulmonary Alveolar Proteinosis and CSF2RA Mutation/R. Tazawa, M. Ito, K. Nakagome, K. Akasaka, H. Ohta, Y. Uchida, A. Shiono, T. Takada, M. Nagata, J. Tohyama, K. Hagiwara, M. Kanazawa, K. Nakata, Niigata, Japan, p.A4141 FENDRR Is an Epigenetic Regulator of Cellular Senescence in Pulmonary Fibroblasts/K. Sakamoto, B. Juan Guardela, G. Yu, J. Herazo-Maya, F. Ahangari, A.E. Tzouvelekis, R. Homer, N. Kaminski, New Haven, CT, p.A4142 Analysis of Long Non-Coding RNA Expression Profiles in the Mouse Model of Pulmonary Fibrosis/H. Sun, J. Chen, W. Qian, J. Kang, J. Wang, L. Jiang, L. Qiao, J. Zhang, Nanjing, China, p.A4143 Identification of Paraquat Aerosolization-Induced Lung Injury and Related Fibrosis in Mice/H. Sun, J. Kang, P. Huang, C.E. Hennessy, L.A. Warg, S.K. Mathai, M.I. Schwarz, C.M. Evans, I.V. Yang, D.A. Schwartz, J. Zhang, Nanjing, China, p.A4144 NEU1 Sialidase Is Elevated in the Lungs of Patients with IPF and Contributes to Fibrosis/I.G. Luzina, V. Lockatell, S.W. Hyun, Z. Noor, A. Liu, E.P. Lillehoj, C. Lee, A. Miranda-Ribera, N.W. Todd, S.E. Goldblum, S.P. Atamas, Baltimore, MD, p.A4145 Interstitial Smooth Muscle Bundles Rather than Activated Myofibroblasts Are Associated with Poor Clinical Outcomes in Patients with Histologic Areas of Organization/I.G. Luzina, A.E. Wyman, A.P. Burke, S.P. Atamas, N.W. Todd, Baltimore, MD, p.A4146 Increased Alveolar Epithelial Cell Senescence in Pulmonary Fibrosis/M. Lehmann, K. Mutze, H.B. Schiller, D.E. Wagner, M. Konigshoff, Munich, Germany, p.A4147 Gene Expression Profiling in End-Stage IPF Lung Fibrotic Microenvironment/J.E. McDonough, F. Ahangari, M. Vukmirovic, G. Deluliis, N. Tanabe, S. Verleden, J. Herazo-Maya, X. Yang, B. Hu, N. Aurelien, G.M. Verleden, B.M. Vanaudenaerde, W. Wuyts, J.C. Hogg, N. Kaminski, Leuven, Belgium, p.A4148 Role of MAP Kinase Phosphatase 5 (MKP5) in Pulmonary Fibrosis/A.E. Tzouvelekis, G. Yu, M. Kisuk, J. Herazo-Maya, T. Woolard, N. Aurelien, M. Vukmirovic, K. Sakamoto, T. Adams, G. DeIuliis, F. Ahangari, A. Bennett, N. Kaminski, New Haven, CT, p.A4149 Disruption of Proximal-Peripheral Epithelial Differentiation and Activation of Hippo/YAP Signaling in Idiopathic Pulmonary Fibrosis/A. Sridharan, A.W. Lange, K.A. Wikenheiser-Brokamp, B. Stripp, J.A. Whitsett, Cincinnati, OH, p.A4150 STAT3 IS a Critical Regulator of Myofibroblast Function and Pulmonary Fibrosis/K.M. Choi, A.J. Haak, K.J. Smith, P.R. Walters, M.A. Thompson, M.R. Freeman, L.J. Manlove, Y.S. Prakash, R. Vassallo, D.J. Tschumperlin, Rochester, MN, p.A4151 MONDAY MORNING ATS 2016 • San Francisco
- Page 1 and 2:
American Thoracic Society Internati
- Page 3:
TABLE OF CONTENTS ATS 2016 INTERNAT
- Page 6 and 7:
2 FRIDAY • MAY 13 PG2A CLINICAL P
- Page 8 and 9:
4 FRIDAY • MAY 13 Target Audience
- Page 10 and 11:
6 FRIDAY • MAY 13 11:15 Case Disc
- Page 12 and 13:
8 FRIDAY • MAY 13 Chairing: H.B.
- Page 14 and 15:
10 FRIDAY • MAY 13 10:25 Advanced
- Page 16 and 17:
12 FRIDAY • MAY 13 Objectives At
- Page 18 and 19:
14 SATURDAY • MAY 14 Abdominal Ul
- Page 20 and 21:
16 SATURDAY • MAY 14 PG17 BASIC
- Page 22 and 23:
18 SATURDAY • MAY 14 1:05 In What
- Page 24 and 25:
20 SATURDAY • MAY 14 10:30 Practi
- Page 26 and 27:
22 SATURDAY • MAY 14 Objectives A
- Page 28 and 29:
24 SATURDAY • MAY 14 10:10 Is My
- Page 30 and 31:
26 SUNDAY • MAY 15 Chairing: D.M.
- Page 32 and 33:
28 SUNDAY • MAY 15 Chronic Cough:
- Page 34 and 35:
30 SUNDAY • MAY 15 • understand
- Page 36 and 37:
32 SUNDAY • MAY 15 Target Audienc
- Page 38 and 39:
34 SUNDAY • MAY 15 Oral Presentat
- Page 40 and 41:
36 SUNDAY • MAY 15 9:15 Hyperpola
- Page 42 and 43:
38 SUNDAY • MAY 15 310 A Smartpho
- Page 44 and 45:
40 SUNDAY • MAY 15 103 Immunosupp
- Page 46 and 47:
42 SUNDAY • MAY 15 A26 POSTER DIS
- Page 48 and 49:
44 SUNDAY • MAY 15 822 Incidence
- Page 50 and 51:
46 SUNDAY • MAY 15 519 Maternal H
- Page 52 and 53:
48 SUNDAY • MAY 15 P14 P15 P16 P1
- Page 54 and 55:
50 SUNDAY • MAY 15 P1545 P1546 Fa
- Page 56 and 57:
52 SUNDAY • MAY 15 P60 P61 Facili
- Page 58 and 59:
54 SUNDAY • MAY 15 P149 P150 Faci
- Page 60 and 61:
56 SUNDAY • MAY 15 P749 P750 P751
- Page 62 and 63:
58 SUNDAY • MAY 15 Facilitator: P
- Page 64 and 65:
60 SUNDAY • MAY 15 P1243 P1244 P1
- Page 66 and 67:
62 SUNDAY • MAY 15 P1295 P1296 P1
- Page 68 and 69:
64 SUNDAY • MAY 15 P1358 P1359 P1
- Page 70 and 71:
66 SUNDAY • MAY 15 P91 Facilitato
- Page 72 and 73:
68 SUNDAY • MAY 15 P616 P617 P618
- Page 74 and 75:
70 SUNDAY • MAY 15 P914 P915 P916
- Page 76 and 77:
72 SUNDAY • MAY 15 P556 P557 P558
- Page 78 and 79:
74 SUNDAY • MAY 15 Facilitators:
- Page 80 and 81:
76 SUNDAY • MAY 15 P997 P998 P999
- Page 82 and 83:
78 SUNDAY • MAY 15 P256 P257 P258
- Page 84 and 85:
80 SUNDAY • MAY 15 A61 THEMATIC P
- Page 86 and 87:
82 SUNDAY • MAY 15 P824 Facilitat
- Page 88 and 89:
84 SUNDAY • MAY 15 P1055 P1056 P1
- Page 90 and 91:
86 SUNDAY • MAY 15 P1101 P1102 P1
- Page 92 and 93:
88 SUNDAY • MAY 15 P1423 P1424 P1
- Page 94 and 95:
90 SUNDAY • MAY 15 P1474 P1475 P1
- Page 96 and 97:
92 SUNDAY • MAY 15 P377 P378 P379
- Page 98 and 99:
94 SUNDAY • MAY 15 P281 P282 P283
- Page 100 and 101:
96 SUNDAY • MAY 15 P450 P451 A74
- Page 102 and 103:
98 SUNDAY • MAY 15 P1562 P1563 P1
- Page 104 and 105:
100 SUNDAY • MAY 15 A80-A THEMATI
- Page 106 and 107:
102 SUNDAY • MAY 15 Facilitator:
- Page 108 and 109:
104 SUNDAY • MAY 15 11:00 a.m.-12
- Page 110 and 111:
106 SUNDAY • MAY 15 L1 U.S. FOOD
- Page 112 and 113:
108 SUNDAY • MAY 15 12:15 Post-Pr
- Page 114 and 115:
110 SUNDAY • MAY 15 MP406 MP407 M
- Page 116 and 117:
112 SUNDAY • MAY 15 clinician and
- Page 118 and 119:
114 SUNDAY • MAY 15 A86 BASIC •
- Page 120 and 121:
116 SUNDAY • MAY 15 Chairing: M.J
- Page 122 and 123:
118 SUNDAY • MAY 15 3:30 High Pre
- Page 124 and 125:
120 SUNDAY • MAY 15 102 Toll-Like
- Page 126 and 127:
122 SUNDAY • MAY 15 A103 POSTER D
- Page 128 and 129:
124 SUNDAY • MAY 15 719 Lactate R
- Page 130 and 131:
126 SUNDAY • MAY 15 1014 Determin
- Page 132 and 133:
128 SUNDAY • MAY 15 611 Plasma Mi
- Page 134 and 135:
130 SUNDAY • MAY 15 412 Daytime S
- Page 136 and 137:
132 SUNDAY • MAY 15 6:30 p.m. - 8
- Page 138 and 139:
134 MONDAY • MAY 16 SS111 SS112 S
- Page 140 and 141:
136 MONDAY • MAY 16 Target Audien
- Page 142 and 143:
138 MONDAY • MAY 16 9:40 Empoweri
- Page 144 and 145:
140 MONDAY • MAY 16 9:28 Endotoxi
- Page 146 and 147:
142 MONDAY • MAY 16 10:15 Adaptiv
- Page 148 and 149:
144 MONDAY • MAY 16 Oral Presenta
- Page 150 and 151: 146 MONDAY • MAY 16 624 Neonatal
- Page 152 and 153: 148 MONDAY • MAY 16 118 Compariso
- Page 154 and 155: 150 MONDAY • MAY 16 912 Should Pa
- Page 156 and 157: 152 MONDAY • MAY 16 1015 Resverat
- Page 158 and 159: 154 MONDAY • MAY 16 718 Health Re
- Page 160 and 161: 156 MONDAY • MAY 16 P152 Facilita
- Page 162 and 163: 158 MONDAY • MAY 16 B35 THEMATIC
- Page 164 and 165: 160 MONDAY • MAY 16 P252 P253 P25
- Page 166 and 167: 162 MONDAY • MAY 16 P406 P407 P40
- Page 168 and 169: 164 MONDAY • MAY 16 P320 Bilatera
- Page 170 and 171: 166 MONDAY • MAY 16 B40 THEMATIC
- Page 172 and 173: 168 MONDAY • MAY 16 P528 P529 Fac
- Page 174 and 175: 170 MONDAY • MAY 16 Facilitator:
- Page 176 and 177: 172 MONDAY • MAY 16 B44 THEMATIC
- Page 178 and 179: 174 MONDAY • MAY 16 P484 P485 P48
- Page 180 and 181: 176 MONDAY • MAY 16 P1161 P1162 P
- Page 182 and 183: 178 MONDAY • MAY 16 B48 THEMATIC
- Page 184 and 185: 180 MONDAY • MAY 16 P1238 P1239 P
- Page 186 and 187: 182 MONDAY • MAY 16 P1297 P1298 P
- Page 188 and 189: 184 MONDAY • MAY 16 Facilitator:
- Page 190 and 191: 186 MONDAY • MAY 16 P15 P16 P17 P
- Page 192 and 193: 188 MONDAY • MAY 16 Facilitator:
- Page 194 and 195: 190 MONDAY • MAY 16 P114 P115 P11
- Page 196 and 197: 192 MONDAY • MAY 16 P1408 Enhance
- Page 198 and 199: 194 MONDAY • MAY 16 P1455 P1456 P
- Page 202 and 203: 198 MONDAY • MAY 16 P1514 P1515 P
- Page 204 and 205: 200 MONDAY • MAY 16 Facilitator:
- Page 206 and 207: 202 MONDAY • MAY 16 P559 P560 P56
- Page 208 and 209: 204 MONDAY • MAY 16 WS3 CLINICAL
- Page 210 and 211: 206 MONDAY • MAY 16 Satellite ear
- Page 212 and 213: 208 MONDAY • MAY 16 Objectives At
- Page 214 and 215: 210 MONDAY • MAY 16 encourage tra
- Page 216 and 217: 212 MONDAY • MAY 16 B82 BEHAVIORA
- Page 218 and 219: 214 MONDAY • MAY 16 B86 BASIC •
- Page 220 and 221: 216 MONDAY • MAY 16 and a number
- Page 222 and 223: 218 MONDAY • MAY 16 2:30 Mortalit
- Page 224 and 225: 220 MONDAY • MAY 16 3:00 Simultan
- Page 226 and 227: 222 MONDAY • MAY 16 525 Clinical
- Page 228 and 229: 224 MONDAY • MAY 16 320 Sensitivi
- Page 230 and 231: 226 MONDAY • MAY 16 113 COPD Subt
- Page 232 and 233: 228 MONDAY • MAY 16 1004 Health C
- Page 234 and 235: 230 MONDAY • MAY 16 609 Skeletal
- Page 236 and 237: 232 MONDAY • MAY 16 5:00 p.m. - 7
- Page 238 and 239: 234 TUESDAY • MAY 17 Chairing: D.
- Page 240 and 241: 236 TUESDAY • MAY 17 CLINICAL YEA
- Page 242 and 243: 238 TUESDAY • MAY 17 This session
- Page 244 and 245: 240 TUESDAY • MAY 17 bronchiectas
- Page 246 and 247: 242 TUESDAY • MAY 17 Target Audie
- Page 248 and 249: 244 TUESDAY • MAY 17 C18 MINI SYM
- Page 250 and 251:
246 TUESDAY • MAY 17 415 Investig
- Page 252 and 253:
248 TUESDAY • MAY 17 207 Survival
- Page 254 and 255:
250 TUESDAY • MAY 17 906 Phenotyp
- Page 256 and 257:
252 TUESDAY • MAY 17 807 The Vali
- Page 258 and 259:
254 TUESDAY • MAY 17 515 Roles of
- Page 260 and 261:
256 TUESDAY • MAY 17 P383 P384 P3
- Page 262 and 263:
258 TUESDAY • MAY 17 Facilitator:
- Page 264 and 265:
260 TUESDAY • MAY 17 P199 P200 P2
- Page 266 and 267:
262 TUESDAY • MAY 17 P620 Facilit
- Page 268 and 269:
264 TUESDAY • MAY 17 P428 P429 P4
- Page 270 and 271:
266 TUESDAY • MAY 17 P442 P443 P4
- Page 272 and 273:
268 TUESDAY • MAY 17 P318 P319 P3
- Page 274 and 275:
270 TUESDAY • MAY 17 P474 P475 Fa
- Page 276 and 277:
272 TUESDAY • MAY 17 Facilitator:
- Page 278 and 279:
274 TUESDAY • MAY 17 P727 P728 P7
- Page 280 and 281:
276 TUESDAY • MAY 17 P774 P775 Fa
- Page 282 and 283:
278 TUESDAY • MAY 17 C53 THEMATIC
- Page 284 and 285:
280 TUESDAY • MAY 17 C55 THEMATIC
- Page 286 and 287:
282 TUESDAY • MAY 17 P1095 P1096
- Page 288 and 289:
284 TUESDAY • MAY 17 P1167 P1168
- Page 290 and 291:
286 TUESDAY • MAY 17 P632 P633 P6
- Page 292 and 293:
288 TUESDAY • MAY 17 P546 P547 P5
- Page 294 and 295:
290 TUESDAY • MAY 17 Facilitator:
- Page 296 and 297:
292 TUESDAY • MAY 17 C65 THEMATIC
- Page 298 and 299:
294 TUESDAY • MAY 17 P659 P660 P6
- Page 300 and 301:
296 TUESDAY • MAY 17 P1506 P1507
- Page 302 and 303:
298 TUESDAY • MAY 17 C70 THEMATIC
- Page 304 and 305:
300 TUESDAY • MAY 17 P1363 P1364
- Page 306 and 307:
302 TUESDAY • MAY 17 P928 P929 P9
- Page 308 and 309:
304 TUESDAY • MAY 17 P973 P974 Fa
- Page 310 and 311:
306 TUESDAY • MAY 17 Facilitator:
- Page 312 and 313:
308 TUESDAY • MAY 17 C80 THEMATIC
- Page 314 and 315:
310 TUESDAY • MAY 17 P98 P99 P100
- Page 316 and 317:
312 TUESDAY • MAY 17 • become a
- Page 318 and 319:
314 TUESDAY • MAY 17 The topics a
- Page 320 and 321:
316 TUESDAY • MAY 17 C85 BASIC
- Page 322 and 323:
318 TUESDAY • MAY 17 C89 BASIC
- Page 324 and 325:
320 TUESDAY • MAY 17 3:20 Pediatr
- Page 326 and 327:
322 TUESDAY • MAY 17 2:45 Long-Te
- Page 328 and 329:
324 TUESDAY • MAY 17 918 Sarcoido
- Page 330 and 331:
326 TUESDAY • MAY 17 410 Effectiv
- Page 332 and 333:
328 TUESDAY • MAY 17 710 Follista
- Page 334 and 335:
330 TUESDAY • MAY 17 509 A Mechan
- Page 336 and 337:
332 TUESDAY • MAY 17 806 Upper Ai
- Page 338 and 339:
334 WEDNESDAY • MAY 18 6:45 Acute
- Page 340 and 341:
336 WEDNESDAY • MAY 18 CLINICAL Y
- Page 342 and 343:
338 WEDNESDAY • MAY 18 Objectives
- Page 344 and 345:
340 WEDNESDAY • MAY 18 D9 BASIC
- Page 346 and 347:
342 WEDNESDAY • MAY 18 Oral Prese
- Page 348 and 349:
344 WEDNESDAY • MAY 18 10:15 Plas
- Page 350 and 351:
346 WEDNESDAY • MAY 18 419 A Nove
- Page 352 and 353:
348 WEDNESDAY • MAY 18 216 Simpli
- Page 354 and 355:
350 WEDNESDAY • MAY 18 815 Multip
- Page 356 and 357:
352 WEDNESDAY • MAY 18 D28 POSTER
- Page 358 and 359:
354 WEDNESDAY • MAY 18 720 Repeat
- Page 360 and 361:
356 WEDNESDAY • MAY 18 P389 Facil
- Page 362 and 363:
358 WEDNESDAY • MAY 18 P439 P440
- Page 364 and 365:
360 WEDNESDAY • MAY 18 P10 P11 P1
- Page 366 and 367:
362 WEDNESDAY • MAY 18 P52 P53 Fa
- Page 368 and 369:
364 WEDNESDAY • MAY 18 P95 P96 P9
- Page 370 and 371:
366 WEDNESDAY • MAY 18 P698 P699
- Page 372 and 373:
368 WEDNESDAY • MAY 18 D42 THEMAT
- Page 374 and 375:
370 WEDNESDAY • MAY 18 P748 Funge
- Page 376 and 377:
372 WEDNESDAY • MAY 18 P353 P354
- Page 378 and 379:
374 WEDNESDAY • MAY 18 P172 P173
- Page 380 and 381:
376 WEDNESDAY • MAY 18 P808 Facil
- Page 382 and 383:
378 WEDNESDAY • MAY 18 P526 P527
- Page 384 and 385:
380 WEDNESDAY • MAY 18 P579 P580
- Page 386 and 387:
382 WEDNESDAY • MAY 18 P944 P945
- Page 388 and 389:
384 WEDNESDAY • MAY 18 P991 P992
- Page 390 and 391:
386 WEDNESDAY • MAY 18 P1036 P103
- Page 392 and 393:
388 WEDNESDAY • MAY 18 P1062 P106
- Page 394 and 395:
390 WEDNESDAY • MAY 18 11:45 Intr
- Page 396 and 397:
392 WEDNESDAY • MAY 18 12:15 Upda
- Page 398 and 399:
394 WEDNESDAY • MAY 18 This sessi
- Page 400 and 401:
396 WEDNESDAY • MAY 18 1:30 The B
- Page 402 and 403:
398 WEDNESDAY • MAY 18 D88 BEHAVI
- Page 404 and 405:
400 WEDNESDAY • MAY 18 3:00 Accel
- Page 406 and 407:
402 WEDNESDAY • MAY 18 D96 MINI S
- Page 408 and 409:
404 WEDNESDAY • MAY 18 604 CARMA3
- Page 410 and 411:
406 WEDNESDAY • MAY 18 702 Potent
- Page 412 and 413:
408 WEDNESDAY • MAY 18 803 ICU Ac
- Page 414 and 415:
410 WEDNESDAY • MAY 18 Chairing:
- Page 416 and 417:
412 WEDNESDAY • MAY 18 404 Interm
- Page 418:
Where today’s science meets tomor